Insider Transactions in Q1 2021 at Ampio Pharmaceuticals, Inc. (AMPE)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Dan Stokely CFO |
SELL
Open market or private sale
|
Direct |
40,000
-58.55%
|
$40,000
$1.83 P/Share
|
|
Mar 16
2021
|
Dan Stokely CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+36.93%
|
$0
$0.43 P/Share
|
|
Feb 12
2021
|
Dan Stokely CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,185
-46.07%
|
$48,370
$2.55 P/Share
|
|
Feb 12
2021
|
Dan Stokely CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
52,500
+33.33%
|
$105,000
$2.55 P/Share
|
|
Jan 04
2021
|
David R Stevens Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+9.13%
|
$13,513
$1.48 P/Share
|
|
Jan 04
2021
|
Philip H Coelho |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+6.23%
|
$13,513
$1.48 P/Share
|
|
Jan 04
2021
|
Richard B Giles |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+4.12%
|
$13,513
$1.48 P/Share
|
|
Jan 04
2021
|
David Bar Or |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+12.71%
|
$13,513
$1.48 P/Share
|